Related Experiment Video
Updated: Jan 23, 2026

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs
Kirstin Hoff1,2, Marta Lemme2,3, Anne-Karin Kahlert1,2,4
1Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Insights
Researchers identified 16 specific DNA methylation sites to accurately distinguish between atrial and ventricular heart tissues and their derived cell types. This DNA methylation profiling offers a rapid method for characterizing cardiomyocytes in cardiovascular research and therapy.
Area of Science:
- Cardiovascular Biology
- Epigenetics
- Stem Cell Biology
Background:
- Accurate cardiac cell type differentiation is crucial for cardiac disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
- Current methods for discriminating cardiac cell types are often time-consuming, expensive, and lack precision.
- DNA methylation is a key epigenetic mechanism involved in early heart development and cardiac cell specification.
Purpose of the Study:
- To investigate DNA methylation patterns in different cardiac tissues.
- To identify specific CpG loci for characterizing cardiac cell types, including hiPSC-CM subtypes.
- To develop a rapid and reliable method for phenotypic evaluation of cardiomyocytes.
Main Methods:
- Genome-wide DNA methylation analysis using Illumina Infinium HumanMethylation450 BeadChips on atrial and ventricular human heart tissues (n=49).
- Validation of atrial-ventricular DNA methylation patterns in an independent cohort using bisulfite pyrosequencing.
- Identification and application of a subset of differentially methylated CpG loci for cardiac tissue and hiPSC-CM characterization.
Main Results:
- Identification of 168 differentially methylated CpG loci between atrial and ventricular human heart tissues.
- Definition of a subset of 16 CpG loci enabling precise characterization of atrial and ventricular cardiac tissues.
- Successful application of these 16 CpG loci for consistent detection of cellular identity in hiPSC-CM subtypes.
Conclusions:
- Testing DNA methylation at a small set of defined CpG sites can reliably distinguish atrial and ventricular cardiac tissues and hiPSC-CM subtypes.
- This DNA methylation profiling method provides a rapid and reliable system for phenotypic characterization of in vitro-generated cardiomyocytes.
- The findings open new opportunities for advancing cardiovascular research and developing patient-specific therapies.
Background:
Cardiac disease modelling using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) requires thorough insight into cardiac cell type differentiation processes. However, current methods to discriminate different cardiac cell types are mostly time-consuming, are costly and often provide imprecise phenotypic evaluation. DNA methylation plays a critical role during early heart development and cardiac cellular specification. We therefore investigated the DNA methylation pattern in different cardiac tissues to identify CpG loci for further cardiac cell type characterization.
Results:
An array-based genome-wide DNA methylation analysis using Illumina Infinium HumanMethylation450 BeadChips led to the identification of 168 differentially methylated CpG loci in atrial and ventricular human heart tissue samples (n = 49) from different patients with congenital heart defects (CHD). Systematic evaluation of atrial-ventricular DNA methylation pattern in cardiac tissues in an independent sample cohort of non-failing donor hearts and cardiac patients using bisulfite pyrosequencing helped us to define a subset of 16 differentially methylated CpG loci enabling precise characterization of human atrial and ventricular cardiac tissue samples. This defined set of reproducible cardiac tissue-specific DNA methylation sites allowed us to consistently detect the cellular identity of hiPSC-CM subtypes.
Conclusion:
Testing DNA methylation of only a small set of defined CpG sites thus makes it possible to distinguish atrial and ventricular cardiac tissues and cardiac atrial and ventricular subtypes of hiPSC-CMs. This method represents a rapid and reliable system for phenotypic characterization of in vitro-generated cardiomyocytes and opens new opportunities for cardiovascular research and patient-specific therapy.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Tissues
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...

